Heart Test Laboratories (NASDAQ:HSCS) vs. Advanced BioMedical Technologies (OTCMKTS:ABMT) Head to Head Review

Advanced BioMedical Technologies (OTCMKTS:ABMT) and Heart Test Laboratories (NASDAQ:HSCS) are both small-cap medical companies, but which is the better business? We will contrast the two businesses based on the strength of their analyst recommendations, earnings, risk, valuation, profitability, institutional ownership and dividends.

Profitability

This table compares Advanced BioMedical Technologies and Heart Test Laboratories’ net margins, return on equity and return on assets.

	Net Margins	Return on Equity	Return on Assets
Advanced BioMedical Technologies	N/A	N/A	N/A
Heart Test Laboratories	N/A	-144.12%	-94.48%

Insider & Institutional Ownership

17.2% of Heart Test Laboratories shares are owned by institutional investors. 34.1% of Advanced BioMedical Technologies shares are owned by company insiders. Comparatively, 1.8% of Heart Test Laboratories shares are owned by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock is poised for long-term growth.

Earnings and Valuation

This table compares Advanced BioMedical Technologies and Heart Test Laboratories”s revenue, earnings per share and valuation.

	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Advanced BioMedical Technologies	$270,000.00	0.16	-$510,000.00	N/A	N/A
Heart Test Laboratories	$14,700.00	238.00	-$6.61 million	($7.91)	-0.45

Advanced BioMedical Technologies has higher revenue and earnings than Heart Test Laboratories.

Analyst Recommendations

This is a summary of current ratings for Advanced BioMedical Technologies and Heart Test Laboratories, as provided by MarketBeat.com.

	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Advanced BioMedical Technologies	0	0	0	0	0.00
Heart Test Laboratories	0	0	2	0	3.00

Heart Test Laboratories has a consensus target price of $13.50, indicating a potential upside of 278.15%. Given Heart Test Laboratories’ stronger consensus rating and higher possible upside, analysts clearly believe Heart Test Laboratories is more favorable than Advanced BioMedical Technologies.

Volatility & Risk

Advanced BioMedical Technologies has a beta of -0.11, indicating that its share price is 111% less volatile than the S&P 500. Comparatively, Heart Test Laboratories has a beta of 2.9, indicating that its share price is 190% more volatile than the S&P 500.

Summary

Heart Test Laboratories beats Advanced BioMedical Technologies on 6 of the 11 factors compared between the two stocks.

About Advanced BioMedical Technologies

Advanced Biomedical Technologies, Inc., a development stage company, designs, develops, manufactures, and markets biomaterial internal fixation devices. It offers polymer osteosynthesis devices, such as surgical screws, binding wires, rods, and related medical devices for the treatment of orthopedic trauma, sports-related medical treatment, cartilage repair, and related treatments, as well as for reconstructive dental procedures. The company was formerly known as Geostar Mineral Corporation and changed its name to Advanced Biomedical Technologies, Inc. in March 2009. Advanced Biomedical Technologies, Inc. was founded in 2002 and is based in New York, New York.

About Heart Test Laboratories

Heart Test Laboratories, Inc., a medical technology company, provides cardiovascular diagnostic devices. The company offers MyoVista wavECG, a resting 12-lead electrocardiograph (ECG) to provide diagnostic information related to cardiac dysfunction, as well as conventional ECG information. It serves clinics, doctor's offices, urgent care centers, and hospitals. The company was incorporated in 2007 and is headquartered in Southlake, Texas.